Physician/Faculty - Division of Hematologic Malignancies, Department of Medical Oncology - Thomas Je
- Employer
- Jefferson Health
- Location
- Philadelphia, Pennsylvania
- Posted Date
- Oct 1, 2024
- Reference
- 9282639
View moreView less
- Specialty
- Faculty, Hematology / Oncology
- Position Type
- Permanent
You need to sign in or create an account to save a job.
Job Details
Thomas Jefferson University, Sidney Kimmel Cancer Center
Faculty Positions - Division of Hematologic Malignancies,
Department of Medical Oncology
The Department of Medical Oncology at Thomas Jefferson University, Sidney Kimmel Cancer Center (SKCC), seeks highly qualified academic physicians in Hematology or Medical Oncology to join the Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation (HMSCT). Candidates must possess an M.D., or D.O. degree, must be BE/BE in Hematology and/or Medical Oncology, and be eligible for a medical license in Pennsylvania.
The ideal candidate will be an outstanding disease-focused early academic physician at the Assistant Professor rank, with a strong focus and some prior experience in clinical research in lymphoma, and potential to build a national reputation as an independent investigator and leader in clinical research. Experience in translational research is of additional interest, but not required. An interest in education and an early track record of mentoring of trainees are also welcome.
The Division of HMSCT, based in center city Philadelphia, comprises faculty that are recognized for excellence in the triple mission of patient care, research and training. Every year, Division faculty and nurses provide complex multidisciplinary and personalized care to hundreds patients with all types of hematologic malignancies, including rare and highly complex blood cancers, attracting referrals nationally and internationally.
The Division is a national leader in the development of new therapies for blood cancers, with a pipeline of clinical trials that is managed by three disease-specific (Lymphoma, Myeloma, and Leukemia/MDS) and one modality-specific (BMT/CART) multidisciplinary disease groups (MDGs) and includes CART- and CAR-NK cell therapies, molecularly targeted therapies, and novel immunotherapies. The Division's clinical trial portfolio is further enhanced by an outstanding Phase I program, in academic partnership with the Sarah Cannon Research Institute (SCRI), and a strong and innovative Health Delivery Research group.
The SKCC is an NCI-designated consortium cancer center that includes researchers from Thomas Jefferson University and Drexel University and offers outstanding shared core facilities. The SKCC is located in the heart of Philadelphia, a vibrant urban cultural scene with an abundance of opportunities for professional and social interactions. Jefferson values diversity and encourages applications from women, members of minority groups, LGBTQ individuals, disabled individuals, and veterans.
Interested individuals should forward their CV as well as a cover letter describing their interests, and the names of three references to: Pierluigi Porcu, MD, Director, Division of Hematologic Malignancies & Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, c/o Le'Ann Robles, Thomas Jefferson University, 834 Chestnut Street, Suite 320, Philadelphia, PA 19107: (email: steven.dawson@jefferson.edu)
Covid Vaccination is a requirement for employment at Jefferson for employees working at Jefferson's clinical entities or at the University. If you are not currently vaccinated you will be required to receive the vaccination prior to hire date if you are offered employment, unless you request and receive an approved medical or religious exemption from Jefferson.
Jefferson includes Thomas Jefferson University and Jefferson Health, a dynamic university and health system with broad reach across the Delaware Valley. Jefferson is the second largest employer in Philadelphia and the largest health system in Philadelphia based on total licensed beds.
Through the merger of Thomas Jefferson University and Philadelphia University in 2017, our University includes ten colleges and four schools. We are an NCAA Division II university and an R2 national doctoral university offering undergraduate and graduate-level programs that provide students with a forward-thinking education in architecture, business, design, engineering, fashion and textiles, health, medicine and social science.
Jefferson Health, the clinical arm of Thomas Jefferson University, has grown from a three-hospital academic health center in 2015, to an 18-hospital health system through mergers and combinations that include hospitals at Abington Health, Aria Health, Kennedy Health, Magee Rehabilitation and Einstein Healthcare Network. We have over 50 outpatient and urgent care centers; ten Magnet®-designated hospitals (recognized by the ANCC for nursing excellence); the NCI-designated Sidney Kimmel Cancer Center (one of only 70 in the country and one of only two in the region); and one of the largest faculty-based telehealth networks in the country. In 2021, Jefferson Health became the sole owner of HealthPartners Plan, a not-for-profit health maintenance organization in Southeastern Pennsylvania. We are the first health system regionally to create an aligned payer-provider partnership.
Jefferson's mission, vision and values create an organization that attracts the best and the brightest students, faculty, staff, and healthcare professionals, as well as the most visionary leaders to drive exceptional results.
As an employer, Jefferson maintains a commitment to provide equal access to employment. Jefferson values diversity and encourages applications from women, members of minority groups, LGBTQ individuals, disabled individuals, and veterans.
Faculty Positions - Division of Hematologic Malignancies,
Department of Medical Oncology
The Department of Medical Oncology at Thomas Jefferson University, Sidney Kimmel Cancer Center (SKCC), seeks highly qualified academic physicians in Hematology or Medical Oncology to join the Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation (HMSCT). Candidates must possess an M.D., or D.O. degree, must be BE/BE in Hematology and/or Medical Oncology, and be eligible for a medical license in Pennsylvania.
The ideal candidate will be an outstanding disease-focused early academic physician at the Assistant Professor rank, with a strong focus and some prior experience in clinical research in lymphoma, and potential to build a national reputation as an independent investigator and leader in clinical research. Experience in translational research is of additional interest, but not required. An interest in education and an early track record of mentoring of trainees are also welcome.
The Division of HMSCT, based in center city Philadelphia, comprises faculty that are recognized for excellence in the triple mission of patient care, research and training. Every year, Division faculty and nurses provide complex multidisciplinary and personalized care to hundreds patients with all types of hematologic malignancies, including rare and highly complex blood cancers, attracting referrals nationally and internationally.
The Division is a national leader in the development of new therapies for blood cancers, with a pipeline of clinical trials that is managed by three disease-specific (Lymphoma, Myeloma, and Leukemia/MDS) and one modality-specific (BMT/CART) multidisciplinary disease groups (MDGs) and includes CART- and CAR-NK cell therapies, molecularly targeted therapies, and novel immunotherapies. The Division's clinical trial portfolio is further enhanced by an outstanding Phase I program, in academic partnership with the Sarah Cannon Research Institute (SCRI), and a strong and innovative Health Delivery Research group.
The SKCC is an NCI-designated consortium cancer center that includes researchers from Thomas Jefferson University and Drexel University and offers outstanding shared core facilities. The SKCC is located in the heart of Philadelphia, a vibrant urban cultural scene with an abundance of opportunities for professional and social interactions. Jefferson values diversity and encourages applications from women, members of minority groups, LGBTQ individuals, disabled individuals, and veterans.
Interested individuals should forward their CV as well as a cover letter describing their interests, and the names of three references to: Pierluigi Porcu, MD, Director, Division of Hematologic Malignancies & Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, c/o Le'Ann Robles, Thomas Jefferson University, 834 Chestnut Street, Suite 320, Philadelphia, PA 19107: (email: steven.dawson@jefferson.edu)
Covid Vaccination is a requirement for employment at Jefferson for employees working at Jefferson's clinical entities or at the University. If you are not currently vaccinated you will be required to receive the vaccination prior to hire date if you are offered employment, unless you request and receive an approved medical or religious exemption from Jefferson.
Jefferson includes Thomas Jefferson University and Jefferson Health, a dynamic university and health system with broad reach across the Delaware Valley. Jefferson is the second largest employer in Philadelphia and the largest health system in Philadelphia based on total licensed beds.
Through the merger of Thomas Jefferson University and Philadelphia University in 2017, our University includes ten colleges and four schools. We are an NCAA Division II university and an R2 national doctoral university offering undergraduate and graduate-level programs that provide students with a forward-thinking education in architecture, business, design, engineering, fashion and textiles, health, medicine and social science.
Jefferson Health, the clinical arm of Thomas Jefferson University, has grown from a three-hospital academic health center in 2015, to an 18-hospital health system through mergers and combinations that include hospitals at Abington Health, Aria Health, Kennedy Health, Magee Rehabilitation and Einstein Healthcare Network. We have over 50 outpatient and urgent care centers; ten Magnet®-designated hospitals (recognized by the ANCC for nursing excellence); the NCI-designated Sidney Kimmel Cancer Center (one of only 70 in the country and one of only two in the region); and one of the largest faculty-based telehealth networks in the country. In 2021, Jefferson Health became the sole owner of HealthPartners Plan, a not-for-profit health maintenance organization in Southeastern Pennsylvania. We are the first health system regionally to create an aligned payer-provider partnership.
Jefferson's mission, vision and values create an organization that attracts the best and the brightest students, faculty, staff, and healthcare professionals, as well as the most visionary leaders to drive exceptional results.
- OUR MISSION: We improve lives.
- OUR VISION: Reimagining health, education and discovery to create unparalleled value
- OUR VALUES: Put People First, Be Bold & Think Differently and Do the Right Thing
As an employer, Jefferson maintains a commitment to provide equal access to employment. Jefferson values diversity and encourages applications from women, members of minority groups, LGBTQ individuals, disabled individuals, and veterans.
Company
Company info
- Website
- http://careers.jefferson.edu/
- Telephone
- 215-503-8219
- Location
-
833 Chestnut Street
Philadelphia
PA
19107
US
Apply for Physician/Faculty - Division of Hematologic Malignancies, Department of Medical Oncology - Thomas Je
Already uploaded your CV? Sign in to apply instantly
Fields marked with an asterisk (*) are required
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert